Ziac is a Oral Tablet, Film Coated in the Human Prescription Drug category. It is labeled and distributed by Teva Women's Health, Inc.. The primary component is Bisoprolol Fumarate; Hydrochlorothiazide.
Product ID | 51285-040_041a5d78-d033-405a-8e2d-5ae64c0b6048 |
NDC | 51285-040 |
Product Type | Human Prescription Drug |
Proprietary Name | Ziac |
Generic Name | Bisoprolol Fumarate And Hydrochlorothiazide |
Dosage Form | Tablet, Film Coated |
Route of Administration | ORAL |
Marketing Start Date | 1993-10-26 |
Marketing Category | NDA / NDA |
Application Number | NDA020186 |
Labeler Name | Teva Women's Health, Inc. |
Substance Name | BISOPROLOL FUMARATE; HYDROCHLOROTHIAZIDE |
Active Ingredient Strength | 10 mg/1; mg/1 |
Pharm Classes | Adrenergic beta-Antagonists [MoA],beta-Adrenergic Blocker [EPC],Increased Diuresis [PE],Thiazide Diuretic [EPC],Thiazides [CS] |
NDC Exclude Flag | N |
Listing Certified Through | 2021-12-31 |
Marketing Start Date | 1993-10-26 |
NDC Exclude Flag | N |
Sample Package? | N |
Marketing Category | NDA |
Application Number | NDA020186 |
Product Type | HUMAN PRESCRIPTION DRUG |
Billing Unit | EA |
Marketing Start Date | 1993-10-26 |
Ingredient | Strength |
---|---|
BISOPROLOL FUMARATE | 10 mg/1 |
SPL SET ID: | 238176e5-df10-457b-a5cf-c950a583e748 |
Manufacturer | |
UNII | |
RxNorm Concept Unique ID - RxCUI |
NDC | Brand Name | Generic Name |
---|---|---|
51285-050 | Ziac | Ziac |
51285-047 | Ziac | Ziac |
51285-040 | Ziac | Ziac |
0093-3241 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide |
0093-3242 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide |
0093-3243 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide |
0185-0707 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide |
0378-0501 | Bisoprolol Fumarate and Hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide |
0378-0503 | Bisoprolol Fumarate and Hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide |
0378-0505 | Bisoprolol Fumarate and Hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide |
10135-740 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide |
10135-741 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide |
10135-742 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide |
10544-173 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide |
10544-174 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide |
10544-563 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide |
21695-808 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide |
21695-809 | Bisoprolol Fumarate and Hydrochlorothiazide | Bisoprolol Fumarate and Hydrochlorothiazide |
29300-187 | bisoprolol fumarate and hydrochlorothiazide | bisoprolol fumarate and hydrochlorothiazide |
Mark Image Registration | Serial | Company Trademark Application Date |
---|---|
ZIAC 74224781 1831849 Live/Registered |
TEVA WOMEN'S HEALTH, LLC 1991-11-25 |